# Is Extracorporeal Membrane Oxygenation a Panacea?

**Authors:** Selen Karaoğlanoğlu, Metin Akgün

PMC · DOI: 10.5152/eurasianjmed.2023.23269 · The Eurasian Journal of Medicine · 2023-12-01

## TL;DR

This paper reviews ECMO's role in critical care, highlighting its life-saving potential and the need for careful patient selection.

## Contribution

The paper provides an updated overview of ECMO applications and patient selection criteria post-pandemic.

## Key findings

- ECMO serves as a life-support technique for severe cardiac or respiratory failure.
- Veno-arterial and veno-venous ECMO have distinct roles in patient care.
- ECMO requires careful evaluation due to its cost and resource demands.

## Abstract

Extracorporeal membrane oxygenation (ECMO) has emerged as a vital life-support technique in critical care medicine, providing temporary circulatory and/or respiratory support for patients with severe cardiac or respiratory failure unresponsive to conventional therapies. This review aims to outline the importance of ECMO and provide a comprehensive overview of its main applications. Two primary types of ECMO, veno-arterial extracorporeal membrane oxygenation and veno-venous extracorporeal membrane oxygenation, serve distinct functions in supporting patients with cardiac or pulmonary dysfunction, respectively. While ECMO offers life-saving potential, its utilization requires careful consideration due to its cost and resource-intensiveness. Thus, a comprehensive evaluation of an individual patient’s clinical condition, prognosis, and potential for recovery is crucial. Ongoing research and technological advancements continually refine ECMO techniques, enhance patient selection criteria, and improve long-term outcomes. Within this narrative review, we present an updated approach to patient selection and ECMO utilization, supported by a detailed literature review. By consolidating the current evidence, we aim to provide healthcare professionals with valuable insights into the ECMO’s post-pandemic role.

## Full-text entities

- **Diseases:** cardiac or pulmonary dysfunction (MESH:D006331), cardiac or respiratory failure (MESH:D012131)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11075031/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11075031/full.md

## References

98 references — full list in the complete paper: https://tomesphere.com/paper/PMC11075031/full.md

---
Source: https://tomesphere.com/paper/PMC11075031